药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
Insulin glulisine
Kaolin
The serum concentration of Dolutegravir can be decreased when it is combined with Kaolin.
Insulin glulisine
Zinc cation
Zinc cation can cause a decrease in the absorption of Dolutegravir resulting in a reduced serum concentration and potentially a decrease in efficacy.
Insulin glulisine
Zinc sulfate, unspecified form
Zinc sulfate, unspecified form can cause a decrease in the absorption of Dolutegravir resulting in a reduced serum concentration and potentially a decrease in efficacy.
Insulin glulisine
Zinc chloride
Zinc chloride can cause a decrease in the absorption of Dolutegravir resulting in a reduced serum concentration and potentially a decrease in efficacy.
Insulin glulisine
Zinc glycinate
Zinc glycinate can cause a decrease in the absorption of Dolutegravir resulting in a reduced serum concentration and potentially a decrease in efficacy.
Insulin glulisine
Zinc acetate
Zinc acetate can cause a decrease in the absorption of Dolutegravir resulting in a reduced serum concentration and potentially a decrease in efficacy.
Insulin glulisine
Zinc ascorbate
Zinc ascorbate can cause a decrease in the absorption of Dolutegravir resulting in a reduced serum concentration and potentially a decrease in efficacy.
Insulin glulisine
Acetylcysteine zinc
Acetylcysteine zinc can cause a decrease in the absorption of Dolutegravir resulting in a reduced serum concentration and potentially a decrease in efficacy.
Insulin glulisine
Zinc gluconate
Zinc gluconate can cause a decrease in the absorption of Dolutegravir resulting in a reduced serum concentration and potentially a decrease in efficacy.
Insulin glulisine
Zinc picolinate
Zinc picolinate can cause a decrease in the absorption of Dolutegravir resulting in a reduced serum concentration and potentially a decrease in efficacy.
Insulin glulisine
Zinc citrate
Zinc citrate can cause a decrease in the absorption of Dolutegravir resulting in a reduced serum concentration and potentially a decrease in efficacy.
Insulin glulisine
Zinc sulfate
Zinc sulfate can cause a decrease in the absorption of Dolutegravir resulting in a reduced serum concentration and potentially a decrease in efficacy.
Insulin glulisine
Zinc oxide
Zinc oxide can cause a decrease in the absorption of Dolutegravir resulting in a reduced serum concentration and potentially a decrease in efficacy.
Insulin glulisine
Polaprezinc
Polaprezinc can cause a decrease in the absorption of Dolutegravir resulting in a reduced serum concentration and potentially a decrease in efficacy.
Insulin glulisine
Zinc Substituted Heme C
Zinc Substituted Heme C can cause a decrease in the absorption of Dolutegravir resulting in a reduced serum concentration and potentially a decrease in efficacy.
Insulin glulisine
Zinc trihydroxide
Zinc trihydroxide can cause a decrease in the absorption of Dolutegravir resulting in a reduced serum concentration and potentially a decrease in efficacy.
Insulin glulisine
Zinc
Zinc can cause a decrease in the absorption of Dolutegravir resulting in a reduced serum concentration and potentially a decrease in efficacy.
Insulin glulisine
Fosamprenavir
The serum concentration of Dolutegravir can be decreased when it is combined with Fosamprenavir.
Insulin glulisine
Aluminium phosphate
Aluminium phosphate can cause a decrease in the absorption of Dolutegravir resulting in a reduced serum concentration and potentially a decrease in efficacy.
Insulin glulisine
Calcium silicate
Calcium silicate can cause a decrease in the absorption of Dolutegravir resulting in a reduced serum concentration and potentially a decrease in efficacy.